Metabolism & Fat BurningRetatrutide
Triple GLP-1/GIP/Glucagon receptor agonist.
/
Metabolism & Fat BurningResearch Peptide
Dual GIP/GLP-1 receptor agonist.
Product Type
Dosage
Price
€67
For research use only. Not for human consumption.
Tirzepatide is a premium dual GIP and GLP-1 receptor agonist developed for advanced laboratory and preclinical research applications. Its unique dual incretin activity has positioned Tirzepatide as one of the most extensively studied compounds in modern metabolic science.
Designed for research environments requiring high-quality experimental materials, Tirzepatide is widely investigated in studies exploring metabolic regulation, glucose homeostasis, appetite signaling, and energy balance.
Each batch is produced under strict quality standards and independently tested to ensure exceptional purity, consistency, and reliability for scientific research applications.
Store refrigerated between 2–8°C before reconstitution. Protect from direct light, excessive heat, and moisture. Maintain appropriate laboratory storage conditions according to established research handling procedures.
This product is intended strictly for scientific and laboratory research purposes only. It is not intended for human consumption, clinical use, diagnosis, treatment, or prevention of any disease.
For research use only. Not for human consumption.
Metabolism & Fat BurningTriple GLP-1/GIP/Glucagon receptor agonist.
Metabolism & Fat BurningLong-acting GLP-1 receptor agonist.
Metabolism & Fat BurningMitochondrial-derived peptide.